CompletedPhase 4NCT00023400
TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB
Studying Primary genito-urinary tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centers for Disease Control and Prevention
- Principal Investigator
- Debra Benator, MD, M.DWashington, D.C. VAMC
- Intervention
- Nelfinavir(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 0 years · All sexes
- Timeline
- 2000 – 2002
Study locations (23)
- Central Arkansas Veterans Health System, Little Rock, Arkansas, United States
- LA County/USC Medical Center, Los Angeles, California, United States
- University of California, San Francisco, San Francisco, California, United States
- Denver Department of Public Health and Hospitals, Denver, Colorado, United States
- Washington, D.C. VAMC, Washington D.C., District of Columbia, United States
- Chicago VA Medical Center (Lakeside), Chicago, Illinois, United States
- Hines VA Medical Center, Hines, Illinois, United States
- Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
- Boston Medical Center, Boston, Massachusetts, United States
- New Jersey Medical School, Newark, New Jersey, United States
- New York University School of Medicine, New York, New York, United States
- Columbia University/Presbyterian Medical Center, New York, New York, United States
- Harlem Hospital Center, New York, New York, United States
- Carolinas Medical Center, Charlotte, North Carolina, United States
- Duke University Medical Center, Durham, North Carolina, United States
- +8 more locations on ClinicalTrials.gov
Collaborators
US Department of Veterans Affairs
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00023400 on ClinicalTrials.govOther trials for Primary genito-urinary tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT05917210Peer-led Implementation of TB-HIV Education and Adherence Counseling in UgandaYale University
- RECRUITINGNCT07312266Questioning the Epidemiology of Asymptomatic TBBarcelona Institute for Global Health
- RECRUITINGNANCT05842161South Africa Smoking Cessation and Engagement in HIV/TB Care CareMassachusetts General Hospital
- RECRUITINGPHASE3NCT05575518A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary TuberculosisStellah Mpagama
- ACTIVE NOT RECRUITINGPHASE4NCT05118490Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis PatientsThe Aurum Institute NPC
- RECRUITINGNANCT05342064Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered ServiceBaylor College of Medicine